Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Multi-metric evaluations of acute psychedelic effects on fMRI brain entropyNature Communications · 2026-06-23Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-04-24An international mega-analysis of psychedelic drug effects on brain circuit functionNature Medicine · 2026-03-31Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-30High hopes? Precision psychedelic addiction medicineFrontiers in Psychiatry · 2026-01-27Psilocybin as a psychophysical adaptogen in chronic pain rehabilitationJournal of Pain · 2025-07-20Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposureFrontiers in Neurology · 2025-06-2458. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-08Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trialNeuropsychopharmacology · 2025-04-08Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.Unknown journal · 2024-12-26Neurochemical characterization of 5-HT2A R partial agonists with simultaneous PET-MRIJournal of Cerebral Blood Flow & Metabolism · 2024-11-28Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human PrimatesProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-11-25Psychedelics as a tool for a more connected and sustainable world? Considering the importance of rituals, boundaries, and commitment.International Journal of Drug Policy · 2024-09-04Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaireJournal of Psychopharmacology · 2024-08-12In vitro and in vivo metabolism of psilocybin’s active metabolite psilocinFrontiers in Pharmacology · 2024-04-28Indigenous psilocybin mushroom practices: An annotated bibliographyJournal of Psychedelic Studies · 2024-02-18Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Unknown journal · 2024-02-15Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivityHeadache The Journal of Head and Face Pain · 2023-12-31Amygdala response to emotional faces following acute administration of psilocybin in healthy individualsNeuroscience Applied · 2023-12-29Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrestsFrontiers in Psychiatry · 2023-08-23Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptomsJournal of Psychopharmacology · 2023-06-29Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021Addiction · 2023-06-06Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trialJournal of Psychopharmacology · 2023-03-19Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2022-12-31A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteersNeuroscience Applied · 2022-12-31Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigationComprehensive Psychoneuroendocrinology · 2022-12-05Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects.NeuroImage · 2022-10-26Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).BMJ Open · 2022-10-13Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.Frontiers in Psychology · 2022-10-04Psychedelics for Alzheimer's Disease Palliative Care.Advances in psychiatry and behavioral health · 2022-08-31Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Frontiers in Pharmacology · 2022-03-08Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.Neuropsychopharmacology · 2022-02-24Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.Unknown journal · 2022-01-26Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.Psychopharmacology · 2022-01-24Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2021-12-31Acute change in functional brain entropy following psilocybin administration in healthy volunteersNeuroscience Applied · 2021-12-31P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsEuropean Neuropsychopharmacology · 2021-11-30P.0828 Psilocybin enhances emotional response to music in healthy individualsEuropean Neuropsychopharmacology · 2021-11-30Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.European Neuropsychopharmacology · 2021-07-07Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of Psychopharmacology · 2021-06-29MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogensNeuropsychopharmacology · 2020-11-19Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry · 2020-11-03P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experienceEuropean Neuropsychopharmacology · 2020-10-31Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humansJournal of Psychopharmacology · 2020-10-07A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor bindingEuropean Neuropsychopharmacology · 2020-03-03Reported effects of psychedelic use on those with low well-being given various emotional states and social contextsDrug Science Policy and Law · 2019-12-31P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levelsEuropean Neuropsychopharmacology · 2019-11-30Motives and Side-Effects of Microdosing With Psychedelics Among UsersThe International Journal of Neuropsychopharmacology · 2019-05-29Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-01-25Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humansEuropean Neuropsychopharmacology · 2018-12-31Horizontal gene cluster transfer increased hallucinogenic mushroom diversity.Evolution Letters · 2018-02-26An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Journal of Psychopharmacology · 2017-01-17Alterations of consciousness and mystical-type experiences after acute LSD in humans.Psychopharmacology · 2016-10-06